DE69225695D1 - Pflaster zur transdermalen Applikation mit einem wirkstoffhaltigem Polymerfilm - Google Patents

Pflaster zur transdermalen Applikation mit einem wirkstoffhaltigem Polymerfilm

Info

Publication number
DE69225695D1
DE69225695D1 DE69225695T DE69225695T DE69225695D1 DE 69225695 D1 DE69225695 D1 DE 69225695D1 DE 69225695 T DE69225695 T DE 69225695T DE 69225695 T DE69225695 T DE 69225695T DE 69225695 D1 DE69225695 D1 DE 69225695D1
Authority
DE
Germany
Prior art keywords
active ingredient
melt
matrix polymer
carrier layer
mucosa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69225695T
Other languages
English (en)
Other versions
DE69225695T2 (de
Inventor
John Wick
Ludwig J Weimann
Wayne C Pollock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Technologies Inc
Original Assignee
Bertek Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bertek Inc filed Critical Bertek Inc
Application granted granted Critical
Publication of DE69225695D1 publication Critical patent/DE69225695D1/de
Publication of DE69225695T2 publication Critical patent/DE69225695T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
DE69225695T 1992-04-01 1992-08-13 Pflaster zur transdermalen Applikation mit einem wirkstoffhaltigem Polymerfilm Expired - Lifetime DE69225695T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86153492A 1992-04-01 1992-04-01

Publications (2)

Publication Number Publication Date
DE69225695D1 true DE69225695D1 (de) 1998-07-02
DE69225695T2 DE69225695T2 (de) 1999-01-21

Family

ID=25336076

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69225695T Expired - Lifetime DE69225695T2 (de) 1992-04-01 1992-08-13 Pflaster zur transdermalen Applikation mit einem wirkstoffhaltigem Polymerfilm

Country Status (10)

Country Link
US (3) US5662926A (de)
EP (1) EP0563507B1 (de)
JP (1) JP3354185B2 (de)
KR (1) KR960005143B1 (de)
AT (1) ATE166574T1 (de)
BR (1) BR9203172A (de)
CA (1) CA2075517C (de)
DE (1) DE69225695T2 (de)
ES (1) ES2118124T3 (de)
MX (1) MX9206090A (de)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6131575A (en) * 1991-01-10 2000-10-17 The Procter & Gamble Company Urinary incontinence device
WO1996000072A1 (en) * 1994-06-23 1996-01-04 The Procter & Gamble Company Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
DE19517145C2 (de) * 1995-05-10 2000-02-24 Hexal Pharmaforschung Gmbh Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
US6245347B1 (en) * 1995-07-28 2001-06-12 Zars, Inc. Methods and apparatus for improved administration of pharmaceutically active compounds
US5980948A (en) * 1996-08-16 1999-11-09 Osteotech, Inc. Polyetherester copolymers as drug delivery matrices
DE19649534B4 (de) 1996-11-29 2004-05-06 Lts Lohmann Therapie-Systeme Ag Verpackung aus Verbundpackstoff zum Verpacken von wirkstoffhaltigen Pflastern
JP2001517216A (ja) * 1997-02-28 2001-10-02 ミネソタ マイニング アンド マニュファクチャリング カンパニー テストステロンデリバリのための経皮デバイス
US5953885A (en) * 1997-04-08 1999-09-21 Retail Communications Corp. Cosmetic sampler and method of making using bulk thin film application techniques
US6691872B1 (en) 1997-04-08 2004-02-17 Aki, Inc. Method of making a cosmetic sampler using bulk thin film application techniques
US6261405B1 (en) 1997-06-27 2001-07-17 Noven Pharmaceuticals, Inc. Method and apparatus for making a patch
DE19728516C2 (de) * 1997-07-04 1999-11-11 Sanol Arznei Schwarz Gmbh TTS zur Verabreichung von Levonorgestrel und gegebenenfalls Estradiol
DE19728517C2 (de) * 1997-07-04 1999-11-11 Sanol Arznei Schwarz Gmbh TTS zur Verabreichung von Sexualsteroidhormonen und Verfahren zu seiner Herstellung
US6767902B2 (en) 1997-09-17 2004-07-27 The Population Council, Inc. Androgen as a male contraceptive and non-contraceptive androgen replacement
US20020012694A1 (en) * 1997-09-17 2002-01-31 Alfred J. Moo-Young Transdermal administration of ment
EP1061802B1 (de) 1997-12-19 2004-07-28 Taro Pharmaceuticals U.S.A., Inc. Topische carbamazepin-formulierungen und deren verwendung
US7491232B2 (en) * 1998-09-18 2009-02-17 Aptus Endosystems, Inc. Catheter-based fastener implantation apparatus and methods with implantation force resolution
DE19821788C1 (de) * 1998-05-15 1999-12-02 Sanol Arznei Schwarz Gmbh Transdermales Therapeutisches System (TTS) Pergolid enthaltend
WO2000018339A1 (en) * 1998-09-29 2000-04-06 Zars, Inc. Methods and apparatus for improved administration of pharmaceutically active compounds
US6475514B1 (en) 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
PL195871B1 (pl) 1998-12-18 2007-11-30 Alza Corp Urządzenie do przezskórnego dostarczania nikotyny
US6270781B1 (en) 1999-01-08 2001-08-07 Maxim Pharmaceuticals, Inc. Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
US6242473B1 (en) 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
US6274168B1 (en) * 1999-02-23 2001-08-14 Mylan Pharmaceuticals Inc. Phenytoin sodium pharmaceutical compositions
AU3932600A (en) * 1999-04-01 2000-10-23 Alza Corporation Transdermal drug delivery devices comprising a polyurethane drug reservoir
US6417227B1 (en) 1999-04-28 2002-07-09 Cg And Associates Methods of delivery of cetyl myristoleate
WO2000076485A1 (fr) * 1999-06-11 2000-12-21 Lintec Corporation Preparation sensible a l'humidite du type a absorption percutanee
FR2795326B1 (fr) * 1999-06-28 2001-08-31 Adir Composition pharmaceutique solide thermoformable a liberation controlee
DE10001546A1 (de) * 2000-01-14 2001-07-19 Beiersdorf Ag Verfahren zur kontinuierlichen Herstellung und Beschichtung von Selbstlebemassen auf Basis von Polyisobutylen mit mindestens einem pharmazeutischen Wirkstoff
WO2001052823A2 (en) 2000-01-20 2001-07-26 Noven Pharmaceuticals, Inc. Compositions to effect the release profile in the transdermal administration of drugs
DE10018834A1 (de) * 2000-04-15 2001-10-25 Lohmann Therapie Syst Lts Transdermale oder transmucosale Darreichungsformen mit einer nicotinhaltigen Wirkstoffkombination zur Raucherentwöhnung
US6682757B1 (en) 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
KR100860822B1 (ko) * 2000-12-21 2008-09-30 주식회사 엘지생활건강 살균, 소독력을 갖는 오염물질 제거용 부착제
DE10110391A1 (de) 2001-03-03 2002-09-26 Lohmann Therapie Syst Lts Hochflexibles Nikotin transdermales therapeutisches System mit Nikotin als Wirkstoff
US20030176379A1 (en) * 2001-05-11 2003-09-18 Raoof Araz A. Antisense permeation enhancers
US7968119B2 (en) * 2001-06-26 2011-06-28 Farrell John J Tamper-proof narcotic delivery system
US20030014947A1 (en) * 2001-07-19 2003-01-23 Sarojini Deevi Laminated metal foil packaging material and method of making
IL160928A0 (en) * 2001-10-19 2004-08-31 Maxim Pharm Inc Use of histamine to treat liver disease
CN1578650A (zh) * 2001-11-06 2005-02-09 马克西姆医药公司 治疗感染性疾病的组合物
WO2003090855A1 (fr) * 2002-04-25 2003-11-06 Centre Pharmapeptides Appareil et ensemble pour l'administration d'un agent antimicrobien
AR033748A1 (es) * 2002-05-15 2004-01-07 Thalas Group Inc Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
DE10317692A1 (de) 2003-04-17 2004-11-11 Lts Lohmann Therapie-Systeme Ag Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut
US7276246B2 (en) * 2003-05-09 2007-10-02 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
US7306812B2 (en) 2003-05-09 2007-12-11 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
US8524272B2 (en) * 2003-08-15 2013-09-03 Mylan Technologies, Inc. Transdermal patch incorporating active agent migration barrier layer
US20050037194A1 (en) * 2003-08-15 2005-02-17 Kimberly-Clark Worldwide, Inc. Thermoplastic polymers with thermally reversible and non-reversible linkages, and articles using same
WO2005032340A2 (en) * 2003-09-29 2005-04-14 Secant Medical, Llc Integral support stent graft assembly
CN100457064C (zh) * 2003-10-28 2009-02-04 诺芬药品公司 透皮递药装置
US20050171192A1 (en) * 2003-12-11 2005-08-04 Gehlsen Kurt R. Use of histamine to treat bone disease
CA2561310C (en) † 2004-03-26 2013-04-23 Csp Technologies, Inc. Active film adhered to flexible packages and method thereof
US20050221036A1 (en) * 2004-04-01 2005-10-06 The Coca-Cola Company Polyester composition with enhanced gas barrier, articles made therewith, and methods
AU2005245407B9 (en) * 2004-05-12 2010-10-14 E.I. Dupont De Nemours And Company Films comprising a liquid-absorbant inner layer, an antimicrobial material and an impermeable outer layer
WO2006009975A2 (en) * 2004-06-22 2006-01-26 Maxim Pharmaceuticals, Inc. Histamine to treat disorders affecting muscle function
US20060252786A1 (en) * 2004-10-21 2006-11-09 The Trustees Of Columbia University Nicotinic-opioid synergy for analgesia
WO2006066244A2 (en) 2004-12-17 2006-06-22 Cash Alan B Method for extending lifespan and delaying the onset of age-related disease
US8545952B2 (en) * 2005-06-07 2013-10-01 The Coca-Cola Company Polyester container with enhanced gas barrier and method
US7820258B2 (en) * 2005-10-05 2010-10-26 The Coca-Cola Company Container and composition for enhanced gas barrier properties
US20070087055A1 (en) * 2005-10-14 2007-04-19 David Jan Directly compressible extended release alprazolam formulation
DE102006026060B4 (de) * 2006-01-12 2013-01-31 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System enthaltend als Wirkstoff Nikotin und Verfahren zur Herstellung solcher Systeme
US7740879B2 (en) * 2006-01-17 2010-06-22 Harrogate Holdings Abuse resistant transdermal drug delivery patch
NZ572207A (en) 2006-03-24 2012-02-24 Auxilium Int Holdings Inc Stabilized compositions containing alkaline labile drugs
WO2007112285A2 (en) 2006-03-24 2007-10-04 Auxilium Pharmaceuticals, Inc. Process for the preparation of a hot-melt extruded laminate
GB2438926A (en) * 2006-06-07 2007-12-12 Paul Marshall Transdermal patch
US8124202B2 (en) * 2006-09-15 2012-02-28 The Coca-Cola Company Multilayer container for enhanced gas barrier properties
US7790077B2 (en) * 2006-09-15 2010-09-07 The Coca-Cola Company Pressurized tooling for injection molding and method of using
DE102006050558B4 (de) * 2006-10-26 2009-03-26 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System enthaltend Norelgestromin zur Kontrazeption und Hormonsubstitution
KR100860824B1 (ko) * 2007-07-25 2008-09-30 주식회사 엘지생활건강 살균, 소독력을 갖는 오염물질 제거용 부착제
US8461389B2 (en) 2008-04-18 2013-06-11 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals
US20100221313A1 (en) * 2008-12-01 2010-09-02 Innovative Pharmaceuticals, Llc Transdermal reservoir patch
CA2757302A1 (en) * 2009-04-01 2010-10-07 Andrew Crockett Methods for treating myofascial, muscle, and/or back pain
CN102427792A (zh) * 2009-05-04 2012-04-25 扎斯制药公司 治疗与神经瘤、神经卡压及其他病况相关联的疼痛的方法
US9186334B2 (en) 2009-05-04 2015-11-17 Nuvo Research Inc. Heat assisted lidocaine and tetracaine for transdermal analgesia
AU2010276456B2 (en) 2009-07-21 2014-07-03 Mylan Inc. Process for the continuous manufacture of a polyisobutylene based transdermal patch
KR20130073893A (ko) 2010-04-13 2013-07-03 나지브 바불 1-메틸-2''-6''-피페콜옥실리디드의 피부 약제학적 조성물 및 사용 방법
DE102010064358A1 (de) * 2010-12-29 2012-07-05 Acino Ag Transdermales Applikationssystem mit überstehender Backingfolie
FR2992325B1 (fr) 2012-06-26 2015-05-22 Ab7 Innovation Matrice sequencee multifonctionnelle monopolymerique en polyurethane coule et procede de fabrication
EP2682113B1 (de) * 2012-07-02 2018-10-31 Luye Pharma AG Verschließen wirkstoffhaltiger Laminate
US9375417B2 (en) 2014-12-04 2016-06-28 Mary's Medicinals LLC Transdermal cannabinoid formulations
US10028904B2 (en) 2014-12-04 2018-07-24 Wisconsin Alumni Research Foundation Transdermal cannabinoid formulations
US20170291020A1 (en) * 2016-04-12 2017-10-12 Mylan Inc. Double disk transdermal system
US10653639B2 (en) 2016-05-16 2020-05-19 Cv Sciences, Inc. Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction
EP3515428B1 (de) 2016-09-22 2023-06-07 Alan B Cash Verfahren zur linderung der symptome von pms
KR101892270B1 (ko) * 2017-04-07 2018-08-27 주식회사 삼양사 피부자극을 최소화 할 수 있는 경피 흡수용 패취 시스템
CA3204220A1 (en) 2021-01-14 2022-07-21 Alan B. Cash Treatment of pathological fatigue with oxaloacetate

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710191A (en) * 1985-12-16 1987-12-01 Jonergin, Inc. Therapeutic device for the administration of medicaments
US5006342A (en) * 1986-12-22 1991-04-09 Cygnus Corporation Resilient transdermal drug delivery device
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
DE3743946A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von nitroglycerin an die haut, verfahren zu ihrer herstellung sowie ihre verwendung
US4839174A (en) 1987-10-05 1989-06-13 Pharmetrix Corporation Novel transdermal nicotine patch
US4943435A (en) 1987-10-05 1990-07-24 Pharmetrix Corporation Prolonged activity nicotine patch
US4840796A (en) * 1988-04-22 1989-06-20 Dow Corning Corporation Block copolymer matrix for transdermal drug release
US4908213A (en) 1989-02-21 1990-03-13 Schering Corporation Transdermal delivery of nicotine

Also Published As

Publication number Publication date
CA2075517A1 (en) 1993-10-02
KR960005143B1 (ko) 1996-04-22
DE69225695T2 (de) 1999-01-21
BR9203172A (pt) 1993-10-19
JPH06335532A (ja) 1994-12-06
US5676969A (en) 1997-10-14
MX9206090A (es) 1993-10-01
ES2118124T3 (es) 1998-09-16
JP3354185B2 (ja) 2002-12-09
EP0563507B1 (de) 1998-05-27
US5662926A (en) 1997-09-02
US5679373A (en) 1997-10-21
KR930021198A (ko) 1993-11-22
CA2075517C (en) 1997-03-11
ATE166574T1 (de) 1998-06-15
EP0563507A1 (de) 1993-10-06

Similar Documents

Publication Publication Date Title
DE69225695D1 (de) Pflaster zur transdermalen Applikation mit einem wirkstoffhaltigem Polymerfilm
DK0464573T3 (da) Plaster med højt indhold af blødgørende indholdsstoffer
CA2177970A1 (en) Plaster containing an active substance
DK0889723T3 (da) Transdermalt terapeutisk system med ringe tykkelse af administreringsareal og stor fleksibilitet samt fremgangsmåde til fremstilling heraf
LV10383A (lv) Transdermala terapeitiska sistema un tas iegusanas panemiens
ES2086319T3 (es) Venda perfeccionada.
ATE209940T1 (de) Verbesserte transdermale vorrichtung mit verringerter delaminierung
ATE78704T1 (de) Transdermale monolithsysteme.
DK0665745T3 (da) Plaster til transdermal administrering af flygtige, farmaceutisk aktive, kemisk basiske indholdsstoffer samt fremgangsmåde
NO172278C (no) Anordning for kontrollert avgivelse av et aktivt stoff til huden
DE69000876D1 (de) Verschlusseinrichtung fuer schrumpfumhuellungen.
ATE109357T1 (de) Transdermales estradiol als therapeutisches sytem.
FI903628A0 (fi) Laitteisto kuumaliimafolion liimaamiseksi
NO952908D0 (no) Nitroglycerolholdig plaster, fremgangsmåte for fremstilling, samt anvendelse av plasteret
ATE64539T1 (de) Dermale und transdermale therapeutische systeme mit musterfoermig aufgetragener klebschicht, sowie verfahren zur dessen herstellung.
ES2138945T3 (es) Sistema de suministro transdermico de farmacos para el tratamiento de enfermedades cardiacas.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R071 Expiry of right

Ref document number: 563507

Country of ref document: EP